Replication of Simian Immunodeficiency Virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo

Virology

Volumn 275, Issue 2, 2000, Pages 391-397

  Margolis, L ^a   Glushakova, S ^a   Chougnet, C ^b   Shearer, G ^b   Markham, P ^c   Robert Guroff, M ^b   Benveniste, R ^b   Miller, C J ^d   Cranage, M ^e   Hirsch, V ^f   Franchini, G ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; INFECTION SENSITIVITY; INGUINAL LYMPH NODE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACACA; MESENTERY LYMPH NODE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0034734798     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0528     Document Type: Article

References (32)

1. Long-term survival of SIVmac251-infected macaques previously immunized with NYVAC-SIV vaccines
2. Recombinant vaccine-induced protection against the highly pathogenic SIV(mac251): Dependence on route of challenge exposure
3. Characterization of clones of HIV-1 infected HuT 78 cells defective in gag gene processing and of SIV clones producing large amounts of envelope glycoprotein
4. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge
5. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers
6. Induction of cellular immune response by subinfectious doses of SIV: Protection from virus challenge
7. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
8. Mucosal infection and vaccine studies with macaques SIV
9. In rive resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose
10. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers
11. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV)
12. Host factors and the pathogenesis of HIV-induced disease
13. Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1
14. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
15. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells
16. Is subunit envelope antigen our best bet for an AIDS vaccine?
17. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes
18. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
19. Induction of CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy
20. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge
21. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
22. Occult systemic infection and persistent simian immunedeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV
23. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia
24. Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIV(mac251)
25. Silent infection of macaques inoculated with low-dose SIV(mac251/spl)
26. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
27. NASBA technology, Isothermal RNA amplification in qualitative and quantitative diagnostics
28. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
29. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
30. Protective immunity against HIV infection: Has nature done the experiment for us?
31. Selective amplification of simian immunedeficiency virus genotypes after intrarectal inoculation of rhesus monkeys
32. Generation of CD8 suppressor factor and β chemokines, induced by xenogenic immunization, in the prevention of simian immunodeficiency virus infection in macaques